NEW YORK (GenomeWeb) – Life sciences tools startup Ultivue announced today that it has closed a $5.2 million Series A financing round that included Arch Venture Partners, Hansjoerg Wyss, and several private investors.

The company was founded to commercialize two fluorescence microscopy technologies, called DNA-PAINT and DNA-Exchange, developed at Harvard University's Wyss Institute for Biologically Inspired Engineering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.